✦ LIBER ✦

Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study

✍ Scribed by Stenlöf, Kaj; Cefalu, William T.; Kim, Kyoung-Ah; Jodar, Esteban; Alba, Maria; Edwards, Robert; Tong, Cindy; Canovatchel, William; Meininger, Gary

Book ID: 121386489
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 737 KB
Volume: 30
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2013.850066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of canagliflozin mon

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

✍ Stenlöf, K.; Cefalu, W. T.; Kim, K.-A.; Alba, M.; Usiskin, K.; Tong, C.; Canovat 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 832 KB

Efficacy and safety of canagliflozin mon

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

✍ Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yut 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 708 KB

Efficacy and safety of dapagliflozin mon

Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise

✍ Kaku, K.; Kiyosue, A.; Inoue, S.; Ueda, N.; Tokudome, T.; Yang, J.; Langkilde, A 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 948 KB

Efficacy and safety of canagliflozin ver

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

✍ Cefalu, William T; Leiter, Lawrence A; Yoon, Kun-Ho; Arias, Pablo; Niskanen, Leo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 489 KB

Fifty-two-week efficacy and safety of vi

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

✍ E. Ferrannini; V. Fonseca; B. Zinman; D. Matthews; B. Ahrén; S. Byiers; Q. Shao; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Long-Term Efficacy and Safety of Canagli

Long-Term Efficacy and Safety of Canagliflozin (CANA) in Older Patients with Type 2 Diabetes Mellitus (T2DM) Over 104 Weeks

✍ Harris, Stewart; Bode, Bruce; Stenlöf, Kaj; Sullivan, Daniel; Fung, Albert; Usis 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 47 KB